Multi‐omic analyses and network biology in cardiovascular disease

Heart disease remains a leading cause of death in North America and worldwide. Despite advances in therapies, the chronic nature of cardiovascular diseases ultimately results in frequent hospitalizations and steady rates of mortality. Systems biology approaches have provided a new frontier toward unraveling the underlying mechanisms of cell, tissue, and organ dysfunction in disease. Mapping the complex networks of molecular functions across the genome, transcriptome, proteome, and metabolome has enormous potential to advance our understanding of cardiovascular disease, discover new disease biomarkers, and develop novel therapies. Computational workflows to interpret these data-intensive analyses as well as integration between different levels of interrogation remain important challenges in the advancement and application of systems biology-based analyses in cardiovascular research. This review will focus on summarizing the recent developments in network biology-level profiling in the heart, with particular emphasis on modeling of human heart failure. We will provide new perspectives on integration between different levels of large "omics" datasets, including integration of gene regulatory networks, protein-protein interactions, signaling networks, and metabolic networks in the heart.

[1]  A. Emili,et al.  Proteomics and phosphoproteomics of failing human left ventricle identifies dilated cardiomyopathy-associated phosphorylation of CTNNA3. , 2023, Proceedings of the National Academy of Sciences of the United States of America.

[2]  T. Lange,et al.  Biomarkers and Coronary Microvascular Dysfunction in Women With Angina and No Obstructive Coronary Artery Disease , 2023, JACC: Advances.

[3]  Joao A. C. Lima,et al.  Association between proteomic biomarkers and myocardial fibrosis measured by MRI: the multi-ethnic study of atherosclerosis , 2023, EBioMedicine.

[4]  S. Ommen,et al.  Multi-Omic Architecture of Obstructive Hypertrophic Cardiomyopathy , 2023, Circulation. Genomic and precision medicine.

[5]  Ying Ge,et al.  Defining the Sarcomeric Proteoform Landscape in Ischemic Cardiomyopathy by Top-Down Proteomics. , 2023, Journal of proteome research.

[6]  Jianyi(Jay) Zhang,et al.  Integrated proteomics reveals alterations in sarcomere composition and developmental processes during postnatal swine heart development. , 2023, Journal of molecular and cellular cardiology.

[7]  R. D. de Boer,et al.  Multi-omics analyses identify molecular signatures with prognostic values in different heart failure aetiologies. , 2022, Journal of molecular and cellular cardiology.

[8]  Bjoern H Menze,et al.  Spatial proteomics in three-dimensional intact specimens , 2022, Cell.

[9]  António S. Barros,et al.  Unveiling Human Proteome Signatures of Heart Failure with Preserved Ejection Fraction , 2022, Biomedicines.

[10]  F. Beuschlein,et al.  Machine learning for classification of hypertension subtypes using multi-omics: A multi-centre, retrospective, data-driven study , 2022, EBioMedicine.

[11]  W. Linke,et al.  Acetylation and phosphorylation changes to cardiac proteins in experimental HFpEF due to metabolic risk reveal targets for treatment. , 2022, Life sciences.

[12]  A. Emili,et al.  Proteomic and phosphoproteomic profiling in heart failure with preserved ejection fraction (HFpEF) , 2022, Frontiers in Cardiovascular Medicine.

[13]  L. Steinmetz,et al.  Transcription Factor GATA4 Regulates Cell Type–Specific Splicing Through Direct Interaction With RNA in Human Induced Pluripotent Stem Cell–Derived Cardiac Progenitors , 2022, Circulation.

[14]  Catherine L. Worth,et al.  Pathogenic variants damage cell composition and single cell transcription in cardiomyopathies , 2022, Science.

[15]  A. Brunner,et al.  Unbiased spatial proteomics with single-cell resolution in tissues. , 2022, Molecular cell.

[16]  X. Yao,et al.  Spatial region-resolved proteome map reveals mechanism of COVID-19-associated heart injury , 2022, Cell Reports.

[17]  A. Conesa,et al.  PaintOmics 4: new tools for the integrative analysis of multi-omics datasets supported by multiple pathway databases , 2022, Nucleic Acids Res..

[18]  B. Molenaar,et al.  Single-cell transcriptomics provides insights into hypertrophic cardiomyopathy. , 2022, Cell reports.

[19]  S. Marx,et al.  Detecting Cardiovascular Protein-Protein Interactions by Proximity Proteomics , 2022, Circulation research.

[20]  H. C. Beck,et al.  Recent Developments in Clinical Plasma Proteomics—Applied to Cardiovascular Research , 2022, Biomedicines.

[21]  E. Zenteno,et al.  An Overview of Glycosylation and its Impact on Cardiovascular Health and Disease , 2021, Frontiers in Molecular Biosciences.

[22]  Huang Huang,et al.  Ischemic preconditioning/ischemic postconditioning alleviates anoxia/reoxygenation injury via the Notch1/Hes1/VDAC1 axis , 2021, Journal of biochemical and molecular toxicology.

[23]  Johann S. Hawe,et al.  Risk Prediction of Cardiovascular Events by Exploration of Molecular Data with Explainable Artificial Intelligence , 2021, International journal of molecular sciences.

[24]  Sean P. Palecek,et al.  Multiomics Method Enabled by Sequential Metabolomics and Proteomics for Human Pluripotent Stem-Cell-Derived Cardiomyocytes. , 2021, Journal of proteome research.

[25]  E. Diamandis,et al.  Uncovering the Depths of the Human Proteome: Antibody-based Technologies for Ultrasensitive Multiplexed Protein Detection and Quantification , 2021, Molecular & cellular proteomics : MCP.

[26]  Rebekah L. Gundry,et al.  Bottom-up proteomic analysis of human adult cardiac tissue and isolated cardiomyocytes , 2021, Journal of molecular and cellular cardiology.

[27]  Peng R. Chen,et al.  Spatiotemporally resolved subcellular phosphoproteomics , 2021, Proceedings of the National Academy of Sciences.

[28]  Kyle A. Brown,et al.  Ultrafast and Reproducible Proteomics from Small Amounts of Heart Tissue Enabled by Azo and timsTOF Pro , 2021, bioRxiv.

[29]  Austė Kanapeckaitė,et al.  Insights into therapeutic targets and biomarkers using integrated multi-'omics' approaches for dilated and ischemic cardiomyopathies. , 2021, Integrative biology : quantitative biosciences from nano to macro.

[30]  I. Iacobucci,et al.  Protein–DNA/RNA Interactions: An Overview of Investigation Methods in the -Omics Era , 2021, Journal of proteome research.

[31]  A. Regev,et al.  Towards a Human Cell Atlas: Taking Notes from the Past. , 2021, Trends in genetics : TIG.

[32]  Robert W. Mills,et al.  Quantitative proteome comparison of human hearts with those of model organisms , 2021, PLoS biology.

[33]  M. Schittmayer,et al.  Mass Spectrometry-Based Redox and Protein Profiling of Failing Human Hearts , 2021, International journal of molecular sciences.

[34]  C. Lenz,et al.  Caveolin3 Stabilizes McT1-Mediated Lactate/Proton Transport in Cardiomyocytes. , 2021, Circulation research.

[35]  Nichollas E. Scott,et al.  An atlas of protein-protein interactions across mouse tissues , 2021, Cell.

[36]  Fabian J Theis,et al.  Ultra‐high sensitivity mass spectrometry quantifies single‐cell proteome changes upon perturbation , 2020, bioRxiv.

[37]  M. Krassowski,et al.  State of the Field in Multi-Omics Research: From Computational Needs to Data Mining and Sharing , 2020, Frontiers in Genetics.

[38]  Nadezhda T. Doncheva,et al.  The STRING database in 2021: customizable protein–protein networks, and functional characterization of user-uploaded gene/measurement sets , 2020, Nucleic Acids Res..

[39]  A. Gramolini,et al.  Membrane proteomic profiling of the heart: Past, present and future. , 2020, American journal of physiology. Heart and circulatory physiology.

[40]  W. Hua,et al.  Plasma Metabolomic Profiles Differentiate Patients With Dilated Cardiomyopathy and Ischemic Cardiomyopathy , 2020, Frontiers in Cardiovascular Medicine.

[41]  Chaoyang Zhang,et al.  A Review of Integrative Imputation for Multi-Omics Datasets , 2020, Frontiers in Genetics.

[42]  P. Ellinor,et al.  Ibrutinib-Mediated Atrial Fibrillation Due to Inhibition of CSK. , 2020, Circulation.

[43]  Zachery R Gregorich,et al.  Distinct hypertrophic cardiomyopathy genotypes result in convergent sarcomeric proteoform profiles revealed by top-down proteomics , 2020, Proceedings of the National Academy of Sciences.

[44]  C. Ottmann,et al.  14-3-3 binding creates a memory of kinase action by stabilizing the modified state of phospholamban , 2020, Science Signaling.

[45]  Ying Zhu,et al.  Automated Coupling of Nanodroplet Sample Preparation with Liquid Chromatography-Mass Spectrometry for High-Throughput Single-Cell Proteomics. , 2020, Analytical chemistry.

[46]  M. Trost,et al.  Technical report: Targeted proteomic analysis reveals enrichment of atypical ubiquitin chains in contractile murine tissues , 2020, bioRxiv.

[47]  M. Savitski,et al.  Thermal proteome profiling for interrogating protein interactions , 2020, Molecular systems biology.

[48]  S. Heymans,et al.  Metabolic Profiling Associates with Disease Severity in Non-Ischemic Dilated Cardiomyopathy. , 2020, Journal of cardiac failure.

[49]  N. Slavov Unpicking the proteome in single cells , 2020, Science.

[50]  Christopher D. Brown,et al.  A Quantitative Proteome Map of the Human Body , 2019, Cell.

[51]  Qiming Liu,et al.  Quantitative proteomics of changes in succinylated proteins expression profiling in left appendages tissue from valvular heart disease patients with atrial fibrillation. , 2019, Clinica chimica acta; international journal of clinical chemistry.

[52]  Catherine L. Worth,et al.  The Translational Landscape of the Human Heart , 2019, Cell.

[53]  Peter Kraft,et al.  Integration of Metabolomic and Other Omics Data in Population-Based Study Designs: An Epidemiological Perspective , 2019, Metabolites.

[54]  Wei Wang,et al.  Unsupervised classification of multi-omics data during cardiac remodeling using deep learning. , 2019, Methods.

[55]  Hani E. Naguib,et al.  A Platform for Generation of Chamber-Specific Cardiac Tissues and Disease Modeling , 2019, Cell.

[56]  Simon C Watkins,et al.  The N-cadherin interactome in primary cardiomyocytes as defined using quantitative proximity proteomics , 2019, Journal of Cell Science.

[57]  Michael E. Hall,et al.  Glycoproteomic Profiling Provides Candidate Myocardial Infarction Predictors of Later Progression to Heart Failure , 2019, ACS omega.

[58]  A. Heck,et al.  Rearrangement of the Protein Phosphatase 1 Interactome During Heart Failure Progression , 2018, Circulation.

[59]  Jonathan W. Nelson,et al.  Bidirectional Control of Coronary Vascular Resistance by Eicosanoids via a Novel GPCR , 2018, bioRxiv.

[60]  Ludovic C. Gillet,et al.  Data‐independent acquisition‐based SWATH‐MS for quantitative proteomics: a tutorial , 2018, Molecular systems biology.

[61]  Peipei Ping,et al.  Quantitative temporal analysis of protein dynamics in cardiac remodeling. , 2018, Journal of molecular and cellular cardiology.

[62]  Bo Wang,et al.  Machine Learning for Integrating Data in Biology and Medicine: Principles, Practice, and Opportunities , 2018, Inf. Fusion.

[63]  David S. Wishart,et al.  MetaboAnalyst 4.0: towards more transparent and integrative metabolomics analysis , 2018, Nucleic Acids Res..

[64]  Min Huang,et al.  Nanoliter-Scale Oil-Air-Droplet Chip-Based Single Cell Proteomic Analysis. , 2018, Analytical chemistry.

[65]  Pengyuan Yang,et al.  In-depth proteomic profiling of left ventricular tissues in human end-stage dilated cardiomyopathy , 2017, Oncotarget.

[66]  Andrew Emili,et al.  Global phosphoproteomic profiling reveals perturbed signaling in a mouse model of dilated cardiomyopathy , 2016, Proceedings of the National Academy of Sciences.

[67]  Ying Ge,et al.  Top-down Proteomics: Technology Advancements and Applications to Heart Diseases , 2016, Expert review of proteomics.

[68]  A. Scholten,et al.  A Proteomics Approach to Identify New Putative Cardiac Intercalated Disk Proteins , 2016, PloS one.

[69]  Caroline H. Johnson,et al.  Metabolomics: beyond biomarkers and towards mechanisms , 2016, Nature Reviews Molecular Cell Biology.

[70]  John M Denu,et al.  Mechanisms and Dynamics of Protein Acetylation in Mitochondria. , 2016, Trends in biochemical sciences.

[71]  Rick B. Vega,et al.  Mitochondrial protein hyperacetylation in the failing heart. , 2016, JCI insight.

[72]  Yong Chen,et al.  Characterization of the cardiac succinylome and its role in ischemia-reperfusion injury. , 2015, Journal of molecular and cellular cardiology.

[73]  C. Ackerley,et al.  Evolutionarily conserved intercalated disc protein Tmem65 regulates cardiac conduction and connexin 43 function , 2015, Nature Communications.

[74]  D. Chan,et al.  Integrated glycoprotein immobilization method for glycopeptide and glycan analysis of cardiac hypertrophy. , 2015, Analytical chemistry.

[75]  Ying Ge,et al.  Effective top-down LC/MS+ method for assessing actin isoforms as a potential cardiac disease marker. , 2015, Analytical chemistry.

[76]  Jennifer E Van Eyk,et al.  Posttranslational modifications of lysine and evolving role in heart pathologies—Recent developments , 2015, Proteomics.

[77]  Euan A Ashley,et al.  RNA-Seq identifies novel myocardial gene expression signatures of heart failure. , 2015, Genomics.

[78]  T. Kislinger,et al.  Proteomic analysis of human fetal atria and ventricle. , 2014, Journal of proteome research.

[79]  Edward T Chouchani,et al.  Ischaemic accumulation of succinate controls reperfusion injury through mitochondrial ROS , 2014, Nature.

[80]  R. Sadygov,et al.  Cardiac mitochondrial proteome dynamics with heavy water reveals stable rate of mitochondrial protein synthesis in heart failure despite decline in mitochondrial oxidative capacity. , 2014, Journal of molecular and cellular cardiology.

[81]  Matthew W. Foster,et al.  Phosphoproteomic Profiling of Human Myocardial Tissues Distinguishes Ischemic from Non-Ischemic End Stage Heart Failure , 2014, PloS one.

[82]  B. Kuster,et al.  Mass-spectrometry-based draft of the human proteome , 2014, Nature.

[83]  Gary D Bader,et al.  A draft map of the human proteome , 2014, Nature.

[84]  J. Stenvang,et al.  Homogenous 96-Plex PEA Immunoassay Exhibiting High Sensitivity, Specificity, and Excellent Scalability , 2014, PloS one.

[85]  S. Carr,et al.  Large-scale identification of ubiquitination sites by mass spectrometry , 2013, Nature Protocols.

[86]  R. Cole,et al.  The Cardiac Acetyl-Lysine Proteome , 2013, PloS one.

[87]  Andrei L. Turinsky,et al.  A Census of Human Soluble Protein Complexes , 2012, Cell.

[88]  Timothy M. D. Ebbels,et al.  Integrated pathway-level analysis of transcriptomics and metabolomics data with IMPaLA , 2011 .

[89]  Christodoulos A. Floudas,et al.  Proteome-wide post-translational modification statistics: frequency analysis and curation of the swiss-prot database , 2011, Scientific reports.

[90]  Ying Ge,et al.  Top-down quantitative proteomics identified phosphorylation of cardiac troponin I as a candidate biomarker for chronic heart failure. , 2011, Journal of proteome research.

[91]  N. de Jonge,et al.  Proteomic profiling of the human failing heart after left ventricular assist device support. , 2011, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[92]  R. Hershberger,et al.  Update 2011: clinical and genetic issues in familial dilated cardiomyopathy. , 2011, Journal of the American College of Cardiology.

[93]  A. Barabasi,et al.  Interactome Networks and Human Disease , 2011, Cell.

[94]  Brian J. Bennett,et al.  Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease , 2011, Nature.

[95]  Sarah B. Scruggs,et al.  Why is it important to analyze the cardiac sarcomere subproteome? , 2010, Expert review of proteomics.

[96]  M. Mann,et al.  Lysine Acetylation Targets Protein Complexes and Co-Regulates Major Cellular Functions , 2009, Science.

[97]  B. Williams,et al.  Mapping and quantifying mammalian transcriptomes by RNA-Seq , 2008, Nature Methods.

[98]  Ralf Steuer,et al.  Review: On the analysis and interpretation of correlations in metabolomic data , 2006, Briefings Bioinform..

[99]  M. V. Regenmortel,et al.  Reductionism and complexity in molecular biology , 2004, HIV/AIDS: Immunochemistry, Reductionism and Vaccine Design.

[100]  Bradford W. Gibson,et al.  Characterization of the human heart mitochondrial proteome , 2003, Nature Biotechnology.

[101]  Jianbo Li,et al.  The gene expression fingerprint of human heart failure , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[102]  Tony Kouzarides,et al.  Acetylation: a regulatory modification to rival phosphorylation? , 2000, The EMBO journal.

[103]  OUP accepted manuscript , 2022, Nucleic Acids Research.

[104]  OUP accepted manuscript , 2021, Database.